Novanta (NOVT) Tops Q4 EPS by 5c, Revenues Beat; Q1 EPS/Revenue Guidance Below Consensus; Offers FY19 EPS/Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2018
February 27, 2019 6:59 AM ESTFull Year 2018 GAAP Revenue of $614.3 million Full Year 2018 GAAP Net Income of $49.1 million Full Year 2018 GAAP Diluted Earnings Per Share of $1.43 Full Year 2018 Adjusted Earnings Per Share of $2.16 Full Year 2018 Adjusted EBITDA of $124 million
BEDFORD, Mass.--(BUSINESS WIRE)-- Novanta Inc. (Nasdaq: NOVT) (the Company), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2018.
Financial Highlights
Three Months Ended December 31, Year Ended December 31, (In millions, except per share amounts) 2018 2017 2018 2017 GAAP Revenue $ 156.2... More